COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,400 Articles (22,816 medRxiv, 8,584 bioRxiv)

Most recent first Previous |  Page 339: Articles 3381-3390  | Next

Analysis the molecular similarity of least common amino acid sites in ACE2 receptor to predict the potential susceptible species for SARS-CoV-2
YeZhi, H., Fan, X., Villalan, A. K., Zhang, S., Joka, F. R., Wu, X., Wang, H., Wang, X.
10.1101/2023.10.13.562198 — Posted: 2023-10-16
V-pipe 3.0: a sustainable pipeline for within-sample viral genetic diversity estimation
Fuhrmann, L., Jablonski, K. P., Topolsky, I., Batavia, A. A., Borgsmueller, N., Icer Baykal, P., Carrara, M., Chen, C., Dondi, A., Dragan, M., Dreifuss, D., John, A., Langer, B., Okoniewski, M., du Plessis, L., Schmitt, U., Singer, F., Stadler, T., Beerenwinkel, N.
10.1101/2023.10.16.562462 — Posted: 2023-10-16
Evaluation of Stroke Risk Following COVID-19 mRNA Bivalent Vaccines Among U.S. Adults Aged >=65 Years
Lu, Y., Matuska, K., Nadimpalli, G., Ma, Y., Duma, N., Zhang, H., Chiang, Y., Lyu, H., Chillarige, Y., Forshee, R. A., Anderson, S. A.
10.1101/2023.10.10.23296624 — Posted: 2023-10-15
Safety of Monovalent BNT162b2 (Pfizer-BioNTech), mRNA-1273 (Moderna), and NVX-CoV2373 (Novavax) COVID-19 Vaccines in US Children Aged 6 months to 17 years
Lloyd, P. C., Hu, M., Shoaibi, A., Feng, Y., Wong, H. L., Smith, E. R., Amend, K. L., Kline, A., Beachler, D. C., Gruber, J. F., Mitra, M., Seeger, J. D., Harris, C., Secora, A., Obidi, J., Wang, J., Song, J., McMahill-Walraven, C. N., Reich, C., McEvoy, R., Do, R., Chillarige, Y., Clifford, R., Cooper, D. D., Forshee, R. A., Anderson, S. A.
10.1101/2023.10.13.23296903 — Posted: 2023-10-15
Ischemic Stroke after Bivalent COVID-19 Vaccination: A Self-Controlled Case Series Study
Xu, S., Sy, L. S., Hong, V., Holmquist, K. J., Qian, L., Farrington, P., Bruxvoort, K. J., Klein, N. P., Fireman, B., Han, B., Lewin, B. J.
10.1101/2023.10.12.23296968 — Posted: 2023-10-15
Longitudinal viscosity of blood plasma for rapid COVID-19 prognostics
Illibauer, J., Clodi-Seitz, T., Zoufaly, A., Aberle, J. H., Weninger, W. J., Foedinger, M., Elsayad, K.
10.1101/2023.10.13.23297016 — Posted: 2023-10-15
Hyperglycemia-induced cathepsin L maturation: Implications for diabetic comorbidities and COVID-19 susceptibility
He, Q., Zhao, M.-M., Li, M.-J., Li, X.-Y., Jin, J.-M., Feng, Y.-M., Zhang, L., Huang, W. J., Yang, F., Yang, J.-K.
10.1101/2023.10.15.23297013 — Posted: 2023-10-15
IFIH1 loss-of-function predisposes to inflammatory and SARS-CoV-2-related infectious diseases
Najm, R., Yavus, L., Jain, R., El Naofal, M., Ramaswamy, S., Abuhammour, W., Loney, T., Nowotny, N., Alsheikh-Ali, A., Abou Tayoun, A., Kandasamy, R.
10.1101/2023.10.13.23297034 — Posted: 2023-10-15
Surveillance and Stability of SARS-CoV-2 Wastewater Samples in Minnesota
Osborn, M., Champeau, S., Meyer, C., Hayden, M., Landini, L., Stark, S., Preeket, S., Vetter, S., Lynfield, R., Huff, D., Schacker, T., Doss, C. R.
10.1101/2023.10.14.23296666 — Posted: 2023-10-15
Omicron COVID-19 Immune Correlates Analysis of a Third Dose of mRNA-1273 in the COVE Trial
Zhang, B., Fong, Y., Fintzi, J., Chu, E., Janes, H. E., Carpp, L. N., Kenny, A., Carone, M., Benkeser, D., van der Laan, L. W. P., Deng, W., Zhou, H., Wang, X., Lu, Y., Yu, C., Borate, B., Houchens, C. R., Martins, K., Jayashankar, L., Huynh, C., Fichtenbaum, C. J., Kalams, S., Gay, C. L., Andrasik, M. P., Kublin, J. G., Corey, L., Neuzil, K. M., Priddy, F., Das, R., Girard, B., El Sahly, H. M., Baden, L. R., Donis, R. O., Koup, R. A., Gilbert, P. B., Follmann, D., United States Government (USG) COVID-19 Immune Assays Team, , Moderna, Inc. Team, , Coronavirus Vaccine Prevention Network (CoVP
10.1101/2023.10.15.23295628 — Posted: 2023-10-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).